Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
about
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseDisease-modifying therapeutic directions for Lewy-Body dementiasMechanisms and therapeutic applications of electromagnetic therapy in Parkinson's diseaseVPS35 regulates cell surface recycling and signaling of dopamine receptor D1Neuroimaging of Parkinson's disease: Expanding views.The neurobiological basis of cognitive impairment in Parkinson's disease.Salience and Default Mode Network Coupling Predicts Cognition in Aging and Parkinson's Disease.Dopaminergic modulation of motor network dynamics in Parkinson's disease.Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive DisordersCerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's DiseaseMedial frontal ∼4-Hz activity in humans and rodents is attenuated in PD patients and in rodents with cortical dopamine depletion.Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like DementiaInfusion of D1 Dopamine Receptor Agonist into Medial Frontal Cortex Disrupts Neural Correlates of Interval Timing.Sex Differences Distinguish Intracortical Glutamate Receptor-Mediated Regulation of Extracellular Dopamine Levels in the Prefrontal Cortex of Adult Rats.Imaging analysis of Parkinson's disease patients using SPECT and tractographyRNA Interference of Human α-Synuclein in Mouse.Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits.Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.Dopamine modulation of learning and memory in the prefrontal cortex: insights from studies in primates, rodents, and birds.Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.Exploring prefrontal cortex functions in healthy humans by transcranial electrical stimulation.Dopamine and Huntington's disease.Dopamine signals and physiological origin of cognitive dysfunction in Parkinson's disease.The Vulnerable Ventral Tegmental Area in Parkinson's Disease.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Catechol-O-Methyltransferase Genotype and Gait Speed Changes over 10 Years in Older Adults.Projection targets of medial frontal D1DR-expressing neurons.Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease.New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease.Startle Habituation and Midfrontal Theta Activity in Parkinson Disease.Quiet connections: Reduced fronto-temporal connectivity in nondemented Parkinson's Disease during working memory encodingString Vessel Formation is Increased in the Brain of Parkinson Disease.Relation between Resting State Front-Parietal EEG Coherence and Executive Function in Parkinson's Disease.Prefrontal D1 dopamine signaling is necessary for temporal expectation during reaction time performance.Separating the effect of reward from corrective feedback during learning in patients with Parkinson's disease.Optogenetic Stimulation of Frontal D1 Neurons Compensates for Impaired Temporal Control of Action in Dopamine-Depleted Mice.Cognitive, Emotional, and Auto-Activation Dimensions of Apathy in Parkinson's Disease.The functional roles of retromer in Parkinson's disease.A human prefrontal-subthalamic circuit for cognitive control.
P2860
Q26750370-BDD71E96-55D5-4D2F-8B18-BD9CFE9070D9Q26782907-5742F8E2-0461-40EA-A6D9-6D76C7FD9D92Q26782971-B5A1F1FC-836D-4C29-8D45-19E4606E8AFBQ28117229-E1F2E7F2-543B-461F-AF0C-489315E899A1Q28387732-EFA57B82-5D86-4FD2-86F7-66FD21BECBC7Q33724698-D84DFE66-4FA6-4512-B1B5-B58713B4A017Q33787942-285D5D1E-FA94-49EA-9C0C-3F673C8B690EQ35119408-C612D6F1-E5B4-4D47-83AC-2D7207B78722Q35795738-E1BDF718-ECE2-4E84-AED3-C52C9D4B6E0EQ35985656-D3EE93F7-FA87-4400-8F07-70861A5CB033Q36106564-80901CAD-7C7A-41B7-906E-92B156ADEC28Q36146776-4FA6576C-D56B-4FBB-BBA1-4CD644F2B2D5Q36265650-9905ABA2-F659-46D4-876F-84154A588D4CQ36462385-A08DECC1-9780-4166-ADCA-8025BF67290AQ37454387-10817060-B1BF-4E75-B5CF-C826EC2C24C4Q37614503-2FA0A53E-2040-482D-82B3-7737870DE178Q37695278-8C869BE7-18C2-4C18-80A7-ED14635262A0Q38199744-811001E6-D41F-4A41-9F90-EA91FAD9411CQ38241529-EE6C5874-0667-402D-9149-5FC6CFE38C2AQ38258699-50E9B28E-E7A0-48BC-86E0-E91730ED4AD2Q38354980-C3337D1C-D063-4F03-809F-45417DF0A2C0Q38379277-627AC591-5FE2-4106-973D-DC102101DBC8Q38379311-6CE6B97B-8E78-4561-A88A-07226F452B86Q38562348-86980E7F-5D2B-441C-91A4-8DA8880E6DA7Q38598375-A94FCD62-B46E-406A-832B-67E1B37C7AA7Q38668018-CE23D51F-F3A5-4176-B88A-28D11D6D1092Q38688137-E7722533-8CFC-4570-B2FC-6C53B4C9D93DQ38734019-112D9282-5970-40D5-9A39-E16701BBCB00Q38805976-729EACAE-243C-47AE-B1E2-D9C52842FDC3Q39172080-15F01001-C1EE-4C50-BC9B-9A0F482B432AQ39601396-6EC57DE2-C70B-4EDC-8FC6-1E731BD7DA53Q39790038-8D215790-9A0A-4854-8AF1-F0A0D2DF5C9CQ40458640-A2B398D9-EA7E-4DC9-8091-8FBD5F9AD77AQ40643957-387C9B12-A0E7-4901-9E69-425AEA426D19Q42831670-5F579902-389C-4534-ABC9-5C9B35597224Q46395485-27D7298C-3B2E-4FE6-9BD8-EF265482B1D7Q46580980-8204D8FD-2207-4148-9401-51D830C196A2Q47111935-325E5D74-C275-41FA-BA51-5C3D0441A91AQ47324789-78B478F1-B0F7-4324-9A87-4561673DCA4BQ47391215-B14F6FA8-4FC5-4799-AC06-9D2FF07BFAC9
P2860
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
@en
type
label
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
@en
prefLabel
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
@en
P2093
P2860
P1476
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
@en
P2093
Ergun Y Uc
Nandakumar S Narayanan
Robert L Rodnitzky
P2860
P304
P356
10.1515/REVNEURO-2013-0004
P577
2013-01-01T00:00:00Z